Expanded Access

As HOOKIPA’s compounds in development are investigational drugs in the preclinical or early clinical development stages without established and confirmed clinical efficacy, safety and overall benefit-profile profile, the company does not currently offer Expanded Access to any of its experimental therapies in any indication at this stage. Participation in one of our clinical trials is the most appropriate way to access any of our investigational therapies. As we progress our clinical development programs, HOOKIPA will continue to assess the emerging clinical data for each individual program and re-evaluate periodically the evolving eligibility requirements for Expanded Access to its investigational drugs.

If you have questions about HOOKIPA Pharma’s expanded access policy, or would like more information about any of our ongoing or planned clinical trials, please contact us directly at office(at)hookipapharma.com.

To learn more about HOOKIPA Pharma’s ongoing clinical trials, please click here.